Gaucher"s disease - ترجمة إلى إنجليزي
Diclib.com
قاموس ChatGPT
أدخل كلمة أو عبارة بأي لغة 👆
اللغة:

ترجمة وتحليل الكلمات عن طريق الذكاء الاصطناعي ChatGPT

في هذه الصفحة يمكنك الحصول على تحليل مفصل لكلمة أو عبارة باستخدام أفضل تقنيات الذكاء الاصطناعي المتوفرة اليوم:

  • كيف يتم استخدام الكلمة في اللغة
  • تردد الكلمة
  • ما إذا كانت الكلمة تستخدم في كثير من الأحيان في اللغة المنطوقة أو المكتوبة
  • خيارات الترجمة إلى الروسية أو الإسبانية، على التوالي
  • أمثلة على استخدام الكلمة (عدة عبارات مع الترجمة)
  • أصل الكلمة

Gaucher"s disease - ترجمة إلى إنجليزي

HUMAN DISEASE CHARACTERIZED BY DEFICIENCY OF THE ENZYME GLUCOCEREBROSIDASE WHICH RESULTS IN THE ACCUMULATION OF HARMFUL QUANTITIES OF THE GLYCOLIPID GLUCOCEREBROSIDE THROUGHOUT THE BODY
Gaucher disease; Gauchers disease; Gauchers Disease; Gaucher Disease; Gaucher disease type 1; Gaucher disease type 2; Gaucher disease type 3; Acid beta-glucosidase deficiency; Cerebroside Lipidosis syndrome; Acute cerebral Gaucher's disease; Anemia, splenic, familial; Gaucher's; Gaucher's Disease; Gaucher’s disease; Pseudo-Gaucher disease; Gaucher syndrome; Erlenmeyer flask deformity of the femur; N370S in the United States; Prevalence of N370S in the United States; Epidemiology of N370S in the United States; National Gaucher Foundation; National Gaucher Foundation (United States)

Gaucher's disease      
Enfermedad de Gaucher, enfermedad genética caracterizada por acumulamiento de grasas en las células de almacenamiento, es causada por la falta de una enzima que diluye las moléculas de azúcar y grasa
S         
  • Proto-Sinaitic Shin
  • Late medieval German script (Swabian [[bastarda]], dated 1496) illustrating the use of long and round ''s'': ''prieſters tochter'' ("priest's daughter").
  • Proto-Sinaitic Shin
  • A letter S in the coat of arms of [[Sortavala]]
19TH LETTER IN THE ENGLISH ALPHABET
Ess; S; User:Soroush.Setodeh; S (letter); ASCII 83; ASCII 115; U+0053; U+0073; Letter S
----
* M.L.S. (Master in Library Science) = Licenciatura en Documentación
* S & T (Science and Technology) = C + T (Ciencia y Tecnología)
* S. = San
* s/he = él o ella
* s.l. (sine loco) = s.l. (sine loco)
* s.n. (sine nomine) = s.n. (sine nomine)
* (S) operator = operador (S)
Alzheimer         
  • 376–1266}}
{{Refend}}
  • A normal brain on the left and a late-stage Alzheimer's brain on the right
  • Stages of [[atrophy]] in Alzheimer's
  • Alois Alzheimer's patient [[Auguste Deter]] in 1902. Hers was the first described case of what became known as Alzheimer's disease.
  • Three-dimensional [[molecular model]] of [[donepezil]], an [[acetylcholinesterase inhibitor]] used in the treatment of Alzheimer's disease symptoms
  • granulovacuolar degeneration bodies]] (bottom center)
  • Intellectual activities such as playing [[chess]] or regular social interaction have been linked to a reduced risk of Alzheimer's disease in epidemiological studies, although no causal relationship has been found.
  • [[Cognitive test]]s such as the [[Mini–Mental State Examination]] (MMSE) can help in the diagnosis of Alzheimer's disease. In this test instructions are given to copy drawings like the one shown, remember some words, read, and subtract numbers serially.
  • Molecular structure of [[memantine]], a medication approved for advanced Alzheimer's disease symptoms
  • PET scan]] of the brain of a person with Alzheimer's disease showing a loss of function in the temporal lobe
  • In Alzheimer's disease, changes in tau protein lead to the disintegration of microtubules in brain cells.
PROGRESSIVE, NEURODEGENERATIVE DISEASE CHARACTERIZED BY MEMORY LOSS
Alzheimers disease; Alzheimer disease; Familial Alzheimer's disease; Alzheimer's; Alzheimer’s Disease; Alzheimer; Altimers; Alzheimers; Alzeihmers; Alzhiemer's disease; Alzheimer’s; DAT - Dementia Alzheimer's type; Alzhimer; Alzhemiers' disease; Alzhiemers; Alzheimer’s diseases; Alzheimer's Research; Alzheimer dementia; Oldtimer's disease; Old timers disease; Alzheimer's diseases; Alzheimer's disease research; Therapies under investigation for Alzheimer's disease; Clinical research to halt Alzheimer's disease & mild cognitve impairment; Alzeheimer's; Alzeheimers; Alstimers; Altzimers; Oldtimer disease; Old timer disease; Old timer's disease; Anti-dementia; Alzheimers Disease; Alzheimer's Disease; Oldtimers disease; Sdat; Alzheimer's dementia; Altzheimer; Alzheimer’s disease; Late-onset Alzheimer's Disease; Anti-dementia drug; Antidementia agent; Anti-dementia agent; Anti-dementia medication; Antidementia medication; Antialzheimer medication; Anti-alzheimer medication; Anti-Alzheimer medication; Anti-Alzheimer's medication; Anti-alzheimer's medication; Antialzheimer's medication; AntiAlzheimer's medication; AntiAlzheimer's drug; Antialzheimer's drug; AntiAlzheimer medication; Anti-alzheimer's drug; Anti-Alzheimer's drug; Anti-Alzheimer drug; AntiAlzheimer drug; Antialzheimer drug; Anti-alzheimer's agent; Antialzheimer's agent; AntiAlzheimer's agent; Anti-Alzheimer's agent; Anti-Alzheimer agent; AntiAlzheimer agent; Antialzheimer agent; Anti-alzheimer agent; Primary degenerative dementia of the Alzheimer's type; Senile dementia of the Alzheimer type; Old-timers' disease; Old-timer's disease; Alzheimer's Syndrome; Alzheimer's research directions; Alzheimer's disease clinical research; Alzheimer's disease and diet; User:Doyeon Koo/sandbox; User:Feliskoo/sandbox; Alzheimer's Disease and Diet; Gamma secretase inhibition; Antialzheimer; Retrogenesis; Alzeimers; Alzeimer's; Alzeimer's disease; Alzeimers disease; Retrogenesis theory; Aluminum Hypothesis; Aluminium hypothesis; Alzheimer's syndrome; Alzheimer's disease research in 2016; 2016 in Alzheimer; Alzeheimer's Disease; Signs and symptoms of Alzheimer's Disease; Causes of Alzheimer's disease; Alzheimers research; Treatment of Alzheimer's disease; Prevention of Alzheimer's disease; Genetic risk factors for Alzheimer's disease; Genetic causes of Alzheimer's disease; Genetics of Alzheimer's disease; Social impact of Alzheimer's disease; Nonfamilial Alzheimer's disease; Sporadic Alzheimer's disease; Management of Alzheimer's disease; Old-timers disease
= Alzheimer
----
* Alzheimer's patient = enfermo de Alzheimer
* Alzheimer's disease = enfermedad de Alzheimer

تعريف

BANDA S
Banda de frecuencias entre 2 y 4 GHz. Utilizado por Sistemas de Distribución MultiCanal, Multipunto (MMDS).

ويكيبيديا

Gaucher's disease

Gaucher's disease or Gaucher disease () (GD) is a genetic disorder in which glucocerebroside (a sphingolipid, also known as glucosylceramide) accumulates in cells and certain organs. The disorder is characterized by bruising, fatigue, anemia, low blood platelet count and enlargement of the liver and spleen, and is caused by a hereditary deficiency of the enzyme glucocerebrosidase (also known as glucosylceramidase), which acts on glucocerebroside. When the enzyme is defective, glucocerebroside accumulates, particularly in white blood cells and especially in macrophages (mononuclear leukocytes, which is often a target for intracellular parasites). Glucocerebroside can collect in the spleen, liver, kidneys, lungs, brain, and bone marrow.

Manifestations may include enlarged spleen and liver, liver malfunction, skeletal disorders or bone lesions that may be painful, severe neurological complications, swelling of lymph nodes and (occasionally) adjacent joints, distended abdomen, a brownish tint to the skin, anemia, low blood platelet count, and yellow fatty deposits on the white of the eye (sclera). Persons seriously affected may also be more susceptible to infection. Some forms of Gaucher's disease may be treated with enzyme replacement therapy.

The disease is caused by a recessive mutation in the GBA gene located on chromosome 1 and affects both males and females. About one in 100 people in the United States are carriers of the most common type of Gaucher disease. The carrier rate among Ashkenazi Jews is 8.9% while the birth incidence is one in 450.

Gaucher's disease is the most common of the lysosomal storage diseases. It is a form of sphingolipidosis (a subgroup of lysosomal storage diseases), as it involves dysfunctional metabolism of sphingolipids.

The disease is named after the French physician Philippe Gaucher, who originally described it in 1882.